Reported Reactions

Devices › Instrument, vitreous aspiration and cutting, ac-powered

Device brand name · Ophthalmic microsurgical unit

Storz Premiere Ophthalmic Microsurgical Unit: medical device reports filed with FDA

370 reports name it, 1996–2000. Manufacturer given most often on reports: Storz Instrument. Product code HQE.

370
device reports naming the brand
0% of all MAUDE reports · about 12 a year
0
reports, 12 months to August 2026
0 in the 12 months before
95.4%
classified as malfunction
56.3% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 370 reports that name the brand "Storz Premiere Ophthalmic Microsurgical Unit" (ophthalmic microsurgical unit), received between September 1996 and October 2000; the manufacturer given most often on reports is Storz Instrument. Spellings of one product vary from report to report.

0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (95.4%) and injury (4.1%); across all instrument, vitreous aspiration and cutting, ac-powered reports (product code HQE) death is recorded in 0% and malfunction in 56.3%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are device issue (59.7%), replace (19.7%) and failure, intermittent (14.6%). The patient problems coded most often are eye injury, surgical procedure and membrane, breakage of. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

No report naming Storz Premiere Ophthalmic Microsurgical Unit was received in the five years to August 2026; the latest was received in October 2000.

By year received

0781561996: 5919961997: 13919971998: 15619981999: 1219992000: 42000

Event type and report source

Event type, as classified on the report

Death0%0
Injury4.1%15
Malfunction95.4%353
Other0%0
Not given0.5%2

Who filed the report

Manufacturer report100%370
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 5,964 reports carrying product code HQE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Device issuea problem with the device22159.7%10.2%
Replace7319.7%9.7%
Failure, intermittent5414.6%1.7%
Aspiration, incomplete308.1%1.9%
Loss of powerthe device lost power308.1%2.4%
Malfunction297.8%1.7%
Failure to calibrate205.4%0.4%
Defective component143.8%1.3%
Sticking102.7%1.2%
Other (for use when an appropriate device code cannot be identified)61.6%4.5%
Reflux within device51.4%0.1%
Suction problem51.4%2.2%
Cautery41.1%0.1%
Power conditioning problem41.1%0.4%
Self-activation or keying41.1%0.3%
Aspiration, excessive30.8%0.2%
Device remains activated30.8%0.3%
System fails to activate30.8%0.1%
Valve(s), sticking30.8%0.1%
Calibration error20.5%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Eye injury205.4%
Surgical procedure41.1%
Membrane, breakage of20.5%
Infective keratitis10.3%
Retinal injury10.3%
Retinal tear10.3%
Surgery, prolonged10.3%
Surgical procedure aborted/stopped10.3%
Therapy/non-surgical treatment, additional10.3%
Treatment with medication(s)10.3%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureStorz Premiere Ophthalmic Microsurgical UnitProduct code HQEAll MAUDE reports
Reports3705,96426,136,888
Share of that pool—6.2%0%
Classified as death, per 1,000 reports009
Classified as injury4.1%42.3%36.2%
Classified as malfunction95.4%56.3%62.3%
Filed by the manufacturer100%95.2%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code HQE

BrandReportsLatest 12 monthsClassified as death
Series Twenty Thousand Legacy2,57300%
Laser Probes512270%
HyperVit Vitrectomy Probe3362210%
Accurus 800cs1,45700%
Backflush Handle DSP233430%
Accurus 600ds21700%
Accurus 400vs52500%
Infiniti Vision System5,25900%
Alcon18020%
Millennium Microsurgical System15200%
Series 20000 Legacy37000%
Viscoat22000.5%
Infiniti Vision System Ozil3,53000%
M Series27,11242.3%
Custom Pak1,26200%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about Storz Premiere Ophthalmic Microsurgical Unit reports

How many FDA reports name Storz Premiere Ophthalmic Microsurgical Unit?

370 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 0 in the latest 12 months.

What kinds of events are reported?

malfunction (95.4%) and injury (4.1%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

device issue (59.7%), replace (19.7%), failure, intermittent (14.6%), aspiration, incomplete (8.1%) and loss of power (8.1%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that Storz Premiere Ophthalmic Microsurgical Unit was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.